Community-acquired urinary tract infections caused by Burkholderiacepacia complex in patients with no underlying risk factor.

JMM case reports Pub Date : 2017-01-31 eCollection Date: 2017-01-01 DOI:10.1099/jmmcr.0.005081
Laila Nimri, Mamuno Sulaiman, Osama Bani Hani
{"title":"Community-acquired urinary tract infections caused by <i>Burkholderia</i><i>cepacia</i> complex in patients with no underlying risk factor.","authors":"Laila Nimri,&nbsp;Mamuno Sulaiman,&nbsp;Osama Bani Hani","doi":"10.1099/jmmcr.0.005081","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> Urinary tract infections (UTIs) remain common infections diagnosed in outpatients as well as hospitalized patients. Community-acquired UTIs are generally caused by <i>Escherichia coli</i> and other members of the family <i>Enterobacteriaceae.</i><i>Burkholderia</i><i>cepacia</i> is an opportunistic pathogen mainly affecting immunocompromised and hospitalized patients, particularly those who have received prior broad-spectrum antibacterial therapy. <b>Case presentation.</b> Urine samples were collected from 157 outpatients clinically diagnosed with UTI and from 100 healthy control subjects. Samples were cultured on differential media and non-motile lactose-non-fermentors were identified via the Remel RapID ONE system. The isolates were tested by the disc diffusion method against 17 antimicrobial agents. <i>Burkholderia</i> was isolated as a single organism from four patients having uncomplicated infections, and one from recurrent infection. None of these patients had an underlying risk factor for this pathogen. Identification of these isolates by the Remel-RapID ONE system was confirmed by <i>recA</i> gene amplification. The four isolates were resistant to lincomycin, nalidixic acid, oxacillin and penicillin G. These cases received monotherapy of oral co-trimoxazole. <b>Conclusions</b>. Our findings alert urologists and diagnostic laboratories to the potential of <i>B.</i><i>cepacia</i> complex infections in similar cases, and that this bacterium should not be ruled out.</p>","PeriodicalId":73559,"journal":{"name":"JMM case reports","volume":"4 1","pages":"e005081"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361629/pdf/","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMM case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/jmmcr.0.005081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

Abstract

Introduction. Urinary tract infections (UTIs) remain common infections diagnosed in outpatients as well as hospitalized patients. Community-acquired UTIs are generally caused by Escherichia coli and other members of the family Enterobacteriaceae.Burkholderiacepacia is an opportunistic pathogen mainly affecting immunocompromised and hospitalized patients, particularly those who have received prior broad-spectrum antibacterial therapy. Case presentation. Urine samples were collected from 157 outpatients clinically diagnosed with UTI and from 100 healthy control subjects. Samples were cultured on differential media and non-motile lactose-non-fermentors were identified via the Remel RapID ONE system. The isolates were tested by the disc diffusion method against 17 antimicrobial agents. Burkholderia was isolated as a single organism from four patients having uncomplicated infections, and one from recurrent infection. None of these patients had an underlying risk factor for this pathogen. Identification of these isolates by the Remel-RapID ONE system was confirmed by recA gene amplification. The four isolates were resistant to lincomycin, nalidixic acid, oxacillin and penicillin G. These cases received monotherapy of oral co-trimoxazole. Conclusions. Our findings alert urologists and diagnostic laboratories to the potential of B.cepacia complex infections in similar cases, and that this bacterium should not be ruled out.

无潜在危险因素的患者由伯克霍尔德deriacepacia复合物引起的社区获得性尿路感染。
介绍。尿路感染(uti)仍然是门诊和住院患者诊断的常见感染。社区获得性尿路感染通常由大肠杆菌和肠杆菌科的其他成员引起。伯克holderacepacia是一种机会性病原体,主要影响免疫功能低下和住院患者,特别是那些先前接受过广谱抗菌药物治疗的患者。案例演示。收集157例临床诊断为尿路感染的门诊患者和100例健康对照者的尿液样本。样品在差异培养基上培养,通过Remel RapID ONE系统鉴定非运动乳糖-非发酵剂。采用圆盘扩散法对分离菌株进行了17种抗菌药物的抑菌试验。从4例无并发症感染患者和1例复发感染患者中分离出伯克霍尔德菌。这些病人都没有感染这种病原体的潜在危险因素。Remel-RapID ONE系统鉴定的分离株经recA基因扩增证实。4株菌株均对林可霉素、萘啶酸、恶西林和青霉素g耐药,均给予口服复方新诺明单药治疗。结论。我们的发现提醒泌尿科医生和诊断实验室注意类似病例中洋葱芽孢杆菌复合感染的可能性,并且不应排除这种细菌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信